Neuphoria Therapeutics
NEUP · NASDAQ
$3.39+$0.08 (+2.42%)TodayMarket closed ·
Prev close $3.31
Who owns NEUP
Largest institutional holders, from their latest 13F filings
| Holder | Shares | % of shares |
|---|---|---|
| Papapetropoulos (Spyros M.D., Ph.D.) | 6.00M | 111.11% |
| Armistice Capital LLC | 1.23M | 22.72% |
| Apeiron Investment Group Ltd | 665.00K | 12.31% |
| Lynx1 Capital Advisors LLC | 599.67K | 11.11% |
| Point72 Asset Management, L.P. | 316.00K | 5.85% |
| Davies (Peter Miles Winston) | 269.98K | 5.00% |
| Wilson (David Ian) | 251.94K | 4.67% |
| Fisher (Alan David) | 100.00K | 1.85% |
| Two Sigma Investments, LP | 42.41K | 0.79% |
| UBS Financial Services, Inc. | 34.90K | 0.65% |
Short interest
Settled Sep 30, 2026
- Shares short
- 20.02K
- Days to cover
- 1.61
- % of shares outstanding
- 0.37%
- Average daily volume
- 12.42K
- Change since last report
- −19.0%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.